TABLE 2—
HIV/AIDS Treatment Program | HCV Treatment Program | Sexually Transmitted Infection Treatment Program | ||||||||||
% of Administrators Reporting “Clear” Program Guidelines | % of Clinicians Reporting “Clear” Program Guidelines | % of Administrators Reporting “Clear” Program Guidelines | % of Clinicians Reporting “Clear” Program Guidelines | % of Administrators Reporting “Clear” Program Guidelines | % of Clinicians Reporting “Clear” Program Guidelines | |||||||
Infection-Related Service | States Without Guidelines | States With Guidelines | States Without Guidelines | States With Guidelines | States Without Guidelines | States With Guidelines | States Without Guidelines | States With Guidelines | States Without Guidelines | States With Guidelines | States Without Guidelines | States With Guidelines |
Provider education | 44 | 64a | 29 | 51a | 37 | 48a | 44 | 48 | 29 | 51* | 37 | 48a |
Patient education | 50 | 68 | 49 | 57 | 45 | 52a | 52 | 51 | 49 | 57 | 45 | 52a |
Patient risk assessment | 57 | 81a | 50 | 69a | 40 | 57a | 51 | 55 | 50 | 69a | 29 | 57a |
Patient counseling | 74 | 77 | 63 | 67 | 56 | 66a | 57 | 69a | 63 | 67 | 56 | 66a |
Medical history and examination | 77 | 77 | 67 | 70 | 43 | 45 | 49 | 40a | 67 | 70 | 43 | 45 |
Biological testing | 59 | 65 | 49 | 52 | 41 | 48a | 48 | 47 | 49 | 52 | 41 | 48a |
Patient medical treatment | 61 | 78a | 57 | 80a | 47 | 57a | 47 | 57a | 57 | 80a | 47 | 57a |
Patient medical monitoring for HIV/AIDS, HCV, and sexually transmitted infections | 62 | 81a | 52 | 73a | 36 | 51a | 44 | 33a | 52 | 73a | 36 | 51a |
Note. HCV = hepatitis C virus.
aDiffered from states without guidelines, P < .05.